Core Question & Context The paradox is the double burden of malnutrition : undernutrition (stunting, wasting, micronutrient gaps) and over-nutrition (overweight/obesity and diet-related NCDs)
By 2005, a synthetic version of a hormone in the venom a GLP-1 receptor agonist was used to treat type 2 diabetes
The future of IVIM Health and GLP-1 therapy The GLP-1 landscape is evolving rapidly
Beyond that window, oxidative degradation and bacterial growth (even with bacteriostatic water) reduce efficacy measurably
While there is still limited research, this recommendation is made out of caution to prevent unwanted pregnancy
Clinical trials have demonstrated that semaglutide users experience an average weight reduction of 15-22% over 68 weeks, making it one of the most effective pharmacological options available for sustainable weight management